National symposium on CSR and the Role of Pharmaceutical Sector in AIDS and TB in India

eHEALTH Bureau

Project Connect, funded by United States Agency for International Development (USAID), a five year program launched by Population Services International (PSI) in association with Federation of Indian Chambers of Commerce and Industry (FICCI), organised a national symposium on, “Corporate Social Responsibility and the Role of Pharmaceutical Sector in response to AIDS and TB in India.” Present at the inaugural session were Dr. S. S. Kudalkar, Program Director – Mumbai District AIDS Control Society MDACS), Mr. SD Joag- Honorary General Secretary, Indian Pharmaceutical Association and Mr. Anand Rudra, Project Management Specialist of United States Agency for International Development(USAID).

Project ‘Connect’, aims to build value added models of Public Private Partnership for HIV/AIDS and TB. It complements the work of the National AIDS Control Program (NACP III). NACP III has highlighted the need for contribution from private health and pharmaceutical to control the spread of HIV/AIDS and TB.

Experts explained the current needs of HIV/AIDS and TB programs where the Pharmaceutical sector can contribute and discuss successful models which saw the involvement of the pharmaceutical sector to strengthen the HIV and TB programmes in India and highlighted the successful involvement of pharma companies like Aurobindo, Emcure, Johnson and Johnson, and Roche in mitigating AIDS and TB in India. He went on to explain the need for such private industry involvement to strengthen the health sector partnerships in India, specifically in HIV and TB prevention and as well as treatment for Tuberculosis.

The symposium also discussed the role being played by pharma sector in its response to HIV/AIDS, and their corporate social responsibility initiatives. The open forum discussed how and why the pharmaceutical sector should come forward in support of PLHIV’s.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video